They have no fiduciary duty in many cases and can profit from customers’ confusion. But where’s the line between unsavory and illegal?

Truist Financial upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Thursday morning, MarketBeat reports.

Bank stocks have had a solid January, and regional-bank stocks, and the ETF, look set to rise for the rest of the year.

Truist Financial analyst Joel Fishbein reiterated a Buy rating on Dynatrace (DT – Research Report) today. The company’s shares closed yesterday ...

Bank of America Securities analyst Ebrahim Poonawala maintained a Buy rating on US Bancorp (USB – Research Report) today. The company’s shares ...

The San Antonio insurance and financial services company didn’t specify how much in financial damages it is seeking from ...

USAA claims to have developed the mobile capture deposit technology and has already successfully sued Discover and Truist, ...

Truist analyst Michael Ciarmoli initiated coverage of Northrop Grumman Corp. NOC and Lockheed Martin Corp LMT with buy ratings because recent drops in their stock prices present a buying opportunity.

Truist shares rose Friday after the company swung to a quarterly profit that beat Wall Street expectations. Shares of the Charlotte, N.C., bank were recently up 4.5% to $46.98. The stock is up ...

(Reuters) - Truist Financial on Friday exceeded Wall Street estimates for fourth-quarter profit, helped by stronger investment banking and trading activity as capital markets strengthened. A resilient ...

The attempted robbery happened at the Truist branch in the 5400 block of South Miami Boulevard. The would-be robber entered the bank and handed ... a CrimeStoppers tip online at ...